Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice

Circulation

Volumn 102, Issue 9, 2000, Pages 1039-1044

  Liuba, Petru ^a   Karnani, Päivi ^d   Pesonen, Erkki ^a   Paakkari, Ilari ^d   Forslid, Anders ^b   Johansson, Leif ^b   Persson, Kenneth ^c   Wadström, Torkel ^b   Laurini, Ricardo ^e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Department of Clinical Microbiology ^*  (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Chlamydia pneumoniae; Endothelium; Nitric oxide; Vasoconstriction

Indexed keywords

DICLOFENAC; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE TONE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034730095     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.9.1039     Document Type: Article

References (46)

1. Is infection with Chlamydia pneumoniae aa causative agent in atherosclerosis?
2. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
3. Infection-associated intimal thickening in the coronary arteries of children
4. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
5. Chlamydia pneumoniae and atherosclerosis: An update
6. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits
7. The role of endothelium in cardiovascular homeostasis and diseases
8. Endothelial dysfunction of coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis
9. Nitric oxide synthesis in atherosclerosis
10. Thromboatherosclerosis in normolipidemic rabbits: A result of continued endothelial damage
11. The physiology and pathophysiology of the nitric oxide/superoxide system
12. Endothelium in control
13. Role of the endothelium in responses of vascular smooth muscle
14. Gene therapy inhibiting neointimal vascular lesion In vivo transfer of endothelial cell nitric oxide synthase gene
15. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions
16. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces expression of adhesion molecules and pro-inflammatory cytokines
17. Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein
18. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilatation
19. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
20. Aspirin improves endothelial dysfunction in atherosclerosis
21. Murine models of Chlamydia pneumoniae infection and atherosclerosis
22. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
23. Atherosclerosis in mice lacking apoE: Evaluation of lesional development and progression
24. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice
25. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries
26. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice
27. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
28. Impairment of endothelium-dependent arterial relaxation by high-fat feeding in apoE-deficient mice: Toward normalization by human apoA-I expression
29. Nitric oxide: Physiology, pathology and pharmacology
30. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary heart disease
31. Role of innate and adaptative immunity in the outcome of primary infection with Chlamydia pneumoniae, as analysed in genetically modified mice
32. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation
33. Diet-induced atherosclerosis increases release of nitrogen oxides from rabbit aorta
34. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
35. Pathogenetic mechanism and epidemiology of Chlamydia pneumoniae
36. Time-dependent inhibition of prostaglandins synthesis by nonsteroidal antiinflammatory drugs: Time-dependent alteration of inhibitory effect and characteristics of its active site
37. Ex vivo assay to determine the cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs
38. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysacchrides that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells
39. Cellular source in ewes of prostaglandin-endoperoxide synthase-2 in uterine arteries following stimulation with lipopolysaccharide
40. Effects of the selective cyclooxygenase-2 inhibitor nimesulide on vascular contractions in endothelium-denuded rat aorta
41. Superoxide anion is an endothelial derived contracting factor
42. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors
43. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric Oxide synthase are selectively up-regulated by steady laminar shear stress
44. Impaired acetylcholine-mediated vasodilatation in patients with congestive heart failure: Role of endothelium-derived vasodilating and vasoconstricting factors
45. Effects of aspirin on endothelial dysfunction in atherosclerosis